Stockreport

Tango Therapeutics GAAP EPS of -$0.29 beats by $0.03, revenue of $0M misses by $0.5M [Seeking Alpha]

Tango Therapeutics, Inc.  (TNGX) 
PDF As of December 31, 2025, the company held $343.1 million in cash, cash equivalents and marketable securities, which the company expects to fund operations into 2028. [Read more]